264 related articles for article (PubMed ID: 18622421)
1. Autologous HSC transplant in t-MDS/AML using cells harvested prior to the development of the secondary malignancy.
Costa LJ; Rodriguez V; Porrata LF; Lacy MQ; Elliott MA; Gertz MA; Gastineau DA; Litzow MR
Bone Marrow Transplant; 2008 Oct; 42(7):497-8. PubMed ID: 18622421
[No Abstract] [Full Text] [Related]
2. Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma.
Abla O; Dror Y; Shago M
Cancer Genet Cytogenet; 2007 Oct; 178(2):168-9. PubMed ID: 17954276
[No Abstract] [Full Text] [Related]
3. Fludarabine as a risk factor for poor stem cell harvest, treatment-related MDS and AML in follicular lymphoma patients after autologous hematopoietic cell transplantation.
Waterman J; Rybicki L; Bolwell B; Copelan E; Pohlman B; Sweetenham J; Dean R; Sobecks R; Andresen S; Kalaycio M
Bone Marrow Transplant; 2012 Apr; 47(4):488-93. PubMed ID: 21572461
[TBL] [Abstract][Full Text] [Related]
4. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
[TBL] [Abstract][Full Text] [Related]
5. Second malignancy following high-dose therapy and autologous stem cell transplantation: incidence and risk factor analysis.
Forrest DL; Nevill TJ; Naiman SC; Le A; Brockington DA; Barnett MJ; Lavoie JC; Nantel SH; Song KW; Shepherd JD; Sutherland HJ; Toze CL; Davis JH; Hogge DE
Bone Marrow Transplant; 2003 Nov; 32(9):915-23. PubMed ID: 14561993
[TBL] [Abstract][Full Text] [Related]
6. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
Au WY; Chan LC; Liang R; Kwong YL
Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
[No Abstract] [Full Text] [Related]
7. Myeloablative therapy, stem cell rescue and gene transfer in advanced Ewing tumors.
Burdach S; Nürnberger W; Laws HJ; Engel BC; Dirksen U; Krauth K; Pape H; Kahn T; Körholz D; Gadner H; Göbel U; Jürgens H
Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S67-8. PubMed ID: 8899179
[No Abstract] [Full Text] [Related]
8. Special clinical concerns/problems in the management of MDS and secondary acute myeloid leukemias.
Venugopal P; Manson S; Preisler HD
Cancer Treat Res; 2001; 108():257-65. PubMed ID: 11702603
[No Abstract] [Full Text] [Related]
9. Treatment of therapy-related acute myelogenous leukemia and myelodysplastic syndromes.
Ballen KK; Antin JH
Hematol Oncol Clin North Am; 1993 Apr; 7(2):477-93. PubMed ID: 8468276
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.
Arana-Yi C; Block AW; Sait SN; Ford LA; Barcos M; Baer MR
Leuk Res; 2008 Jul; 32(7):1043-8. PubMed ID: 18093651
[TBL] [Abstract][Full Text] [Related]
11. Does autologous transplantation directly increase the risk of secondary leukemia in lymphoma patients?
Hake CR; Graubert TA; Fenske TS
Bone Marrow Transplant; 2007 Jan; 39(2):59-70. PubMed ID: 17143301
[TBL] [Abstract][Full Text] [Related]
12. Risk of secondary myeloid leukemia and myelodysplastic syndrome following standard-dose chemotherapy or high-dose chemotherapy with stem cell support in patients with potentially curable malignancies.
Kollmannsberger C; Hartmann JT; Kanz L; Bokemeyer C
J Cancer Res Clin Oncol; 1998; 124(3-4):207-14. PubMed ID: 9619748
[TBL] [Abstract][Full Text] [Related]
13. Secondary malignancies after therapy of indolent non-Hodgkin's lymphoma.
Friedberg JW
Haematologica; 2008 Mar; 93(3):336-8. PubMed ID: 18310538
[No Abstract] [Full Text] [Related]
14. Secondary primary malignancies in patients with multiple myeloma treated with high-dose chemotherapy and autologous blood stem cell transplantation.
Fenk R; Neubauer F; Bruns I; Schröder T; Germing U; Haas R; Kobbe G
Br J Haematol; 2012 Mar; 156(5):683-6. PubMed ID: 22050384
[No Abstract] [Full Text] [Related]
15. Therapy for metastatic ESFT: is it time to ask new questions?
Snyder KM; Mackall CL
Pediatr Blood Cancer; 2007 Aug; 49(2):115-6. PubMed ID: 17474114
[No Abstract] [Full Text] [Related]
16. [Four cases of therapy-related leukemia in multiple myeloma].
Natori K; Izumi H; Kaneko K; Ishihara S; Nagase D; Fujimoto Y; Kato M; Umeda M; Kuraishi Y
Gan To Kagaku Ryoho; 2007 Jan; 34(1):121-4. PubMed ID: 17220686
[TBL] [Abstract][Full Text] [Related]
17. Philadelphia chromosome-positive acute lymphoblastic leukemia secondary to chemoradiotherapy for Ewing sarcoma. Report of two cases and concise review of the literature.
Snyder DS; Stein AS; O'Donnell MR; Gaal K; Slovak ML; Forman SJ
Am J Hematol; 2005 Jan; 78(1):74-8. PubMed ID: 15609284
[TBL] [Abstract][Full Text] [Related]
18. Porphyria cutanea tarda in a patient with post-transplant MDS.
Oubre D; Cruz J; Keung Y
Bone Marrow Transplant; 2001 Jan; 27(2):219-20. PubMed ID: 11281395
[TBL] [Abstract][Full Text] [Related]
19. Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.
Coorens THH; Collord G; Lu W; Mitchell E; Ijaz J; Roberts T; Oliver TRW; Burke GAA; Gattens M; Dickens E; Nangalia J; Tischkowitz M; Anderson J; Shlien A; Godfrey AL; Murray MJ; Behjati S
Blood; 2021 May; 137(21):2992-2997. PubMed ID: 33598691
[No Abstract] [Full Text] [Related]
20. Therapy-related myelodysplastic syndromes.
Park DJ; Koeffler HP
Semin Hematol; 1996 Jul; 33(3):256-73. PubMed ID: 8819235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
